Jennifer McClure, PhD

Associate Director of Faculty, Research, & DevelopmentĀ 
Senior Investigator

206-287-2737
mcclure.j@ghc.org

Recent publications

Curriculum vitae (CV)

 

Research interests and experience

  • Behavior change: developing and implementing action-oriented and motivational interventions for smoking cessation; dietary change; physical activity promotion; health communications and informed medical decision making to promote behavior
  • Behavioral health: comorbid psychological and behavioral risk factors
  • Cancer control: preventive behaviors
  • Chronic illness management: prevention; disease management; treatment adherence
  • Health informatics: Web-based and other computer-delivered interventions
  • Population-based behavioral interventions
  • Pharmacogenomics: nicotine addiction

Jennifer McClure's research aims to promote healthy behaviors in a way that real people can relate to. Her comprehensive approach focuses on forging meaningful connections with people to help them identify and overcome individual barriers and make healthy, long-term lifestyle choices. She also strives to create treatment programs that augment standard medical care and are accessible and acceptable to the public.

Known for key research in smoking cessation treatment, Dr. McClure is a clinical psychologist with particular interest in finding ways to motivate smokers to start treatment, stop smoking, and stay abstinent. Her research has emphasized use of phone counseling and Internet-delivered interventions, with a focus on treatment tailoring and identifying the most effective messages for promoting behavior change. Dr. McClure's practical intervention approach is strengthened by her attention to comorbid risk factors, as reflected in recent work in the "Step Up" study to develop a program designed to simultaneously treat depression, smoking, and sedentary behavior.

Dr. McClure frequently collaborates with other institutions in the HMO Research Network, SRI International, and the University of Michigan Center for Health Communications Research. She has led GHRI's participation in many multisite projects with these partners addressing smoking cessation treatment, healthy eating, online informed-decision aids for breast cancer chemoprevention, and the pharmacogenomics of nicotine addiction.

Dr. McClure's proven record of innovative science and effective leadership led to her appointment as GHRI Associate Director for Research, Internal in 2008. This follows her long-time tenure on the GHRI Scientific Policy Committee. Dr. McClure is a member of several professional organizations, including the Society for Research on Nicotine and Tobacco, Society of Behavioral Medicine, and Division 38 (Health Psychology) of the American Psychological Association. She serves on Group Health's Tobacco and Alcohol Prevention Team and is an associate editor for Nicotine and Tobacco Research.

Dr. McClure is an Affiliate Professor in the Department of Health Services in the University of Washington's School of Public Health, and an Affiliate Investigator in the Division of Public Health Sciences at the Fred Hutchinson Cancer Research Center.

Related information:

Top

Recent publications

Green BB, Anderson ML, Cook AJ, Catz S, Fishman P, McClure JB, Reid R. Using body mass index data in the electronic health record to calculate cardiovascular risk. Am J Prev Med. 2012;42:342-7. PubMed

Cofta-Woerpel L, McClure JB, Li Y, Urbauer D, Cinciripini PM, Wetter DW. Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol. 2011 Aug;120(3):596-606. PubMed

Dillard AJ, Ubel PA, Smith DM, Zikmund-Fisher BJ, Nair V, Derry HA, Zhang A, Pitsch RK, Alford SH, McClure JB, Fagerlin A. The distinct role of comparative risk perceptions in a breast cancer prevention program. Ann Behav Med. 2011 Oct;42(2):262-8.

Reitzel LR, McClure JB, Cofta-Woerpel L, Mazas CA, Cao Y, Cinciripini PM, Vidrine JI, Li Y, Wetter DW. The efficacy of computer-delivered treatment for smoking cessation. Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1555-7. Epub 2011 May 25. PubMed

Wetter DW, McClure JB, Cofta-Woerpel L, Costello TJ, Reitzel LR, Businelle MS, Cinciripini PM. A randomized clinical trial of a palmtop computer-delivered treatment for smoking relapse prevention among women. Psychol Addict Behav. 2011 Jun;25(2):365-71. PubMed

Fagerlin A, Dillard AJ, Smith DM, Zikmund-Fisher BJ, Pitsch R, McClure JB, Greene S, Alford SH, Nair V, Hayes DF, Wiese C, Ubel PA. Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid. Breast Cancer Res Treat. 2011 Jun;127(3):681-8. Epub 2011 Mar 26. PubMed

Swan GE, Javitz HS, Jack LM, Wessel J, Michel M, Hinds DA, Stokowksi RP, McClure JB, Catz SL, Richards J, Zbikowski SM, Deprey M, McAfee T, Conti DV, Bergen AW. Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J. 2011 May 24. [Epub ahead of print]. PubMed

Zbikowski SM, Jack LM, McClure JB, Deprey M, Javitz HS, McAfee TA, Catz SL, Richards J, Bush T, Swan GE. Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine Tob Res. 2011 May;13(5):319-27. Epub 2011 Jan 31. PubMed

Catz SL, Jack LM, McClure JB, Javitz HS, Deprey M, Zbikowski SM, McAfee T, Richards J, Swan GE. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011 May;13(5):361-8. Epub 2011 Feb 24. PubMed

McClure JB, Catz SL, Ludman EJ, Richards J, Riggs K, Grothaus L. Feasibility and acceptability of a multiple risk factor intervention: The Step Up randomized pilot trial. BMC Public Health. 2011 Mar 17;11:167. PubMed

To view more publications, please see Dr. McClure's CV.

Top